Can the evolution of male contraception lead to a revolution? Review of the current state of knowledge.

about

Can the evolution of male contraception lead to a revolution? Review of the current state of knowledge.

Item

http://www.wikidata.org/entity/Q55346784

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Can the evolution of male cont ...... he current state of knowledge.

@en

Can the evolution of male cont ...... he current state of knowledge.

@nl

type

Item

label

Can the evolution of male cont ...... he current state of knowledge.

@en

Can the evolution of male cont ...... he current state of knowledge.

@nl

prefLabel

Can the evolution of male cont ...... he current state of knowledge.

@en

Can the evolution of male cont ...... he current state of knowledge.

@nl

P1476

Can the evolution of male cont ...... he current state of knowledge.

@en

P2093

Marcin Matuszewski

http://www.w3.org/2001/XMLSchema#string

Mikołaj Frankiewicz

http://www.w3.org/2001/XMLSchema#string

Wojciech Połom

http://www.w3.org/2001/XMLSchema#string

P2860

AF-2364 [1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide] is a potential male contraceptive: a review of recent data

Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.

Safety and effectiveness of vasectomy.

Phase II clinical trial of a vas deferens injectable contraceptive for the male.

A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive.

Current Contraceptive Use and Variation by Selected Characteristics Among Women Aged 15-44: United States, 2011-2013.

Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group.

TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN

A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.

The low gonadotropin-independent constitutive production of testicular testosterone is sufficient to maintain spermatogenesis.

P304

108-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5173/CEJU.2017.1450

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29732216

http://www.w3.org/2001/XMLSchema#string

P921

contraception

P932

5926633

http://www.w3.org/2001/XMLSchema#string